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Abstract
Objective
Blood-brain barrier (BBB) permeability has been proposed as a predictor of hemorrhagic
transformation (HT) after tissue plasminogen activator (tPA) administration; however, the
reliability of perfusion computed tomography (PCT) permeability imaging for predicting HT
is uncertain.
We aimed to determine the performance of high-permeability region size on PCT (HPrs-
PCT) in predicting HT after intravenous tPA administration in patients with acute stroke.
Methods
We performed a multimodal CT protocol (non-contrast CT, PCT, CT angiography) to pro-
spectively study patients with middle cerebral artery occlusion treated with tPA within 4.5
hours of symptom onset. HT was graded at 24 hours using the European-Australasian
Acute Stroke Study II criteria. ROC curves selected optimal volume threshold, and multivari-
ate logistic regression analysis identified predictors of HT.
Results
The study included 156 patients (50% male, median age 75.5 years). Thirty-seven (23,7%)
developed HT [12 (7,7%), parenchymal hematoma type 2 (PH-2)]. At admission, patients
with HT had lower platelet values, higher NIHSS scores, increased ischemic lesion volumes,
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larger HPrs-PCT, and poorer collateral status. The negative predictive value of HPrs-PCT at
a threshold of 7mL/100g/min was 0.84 for HT and 0.93 for PH-2. The multiple regression
analysis selected HPrs-PCT at 7mL/100g/min combined with platelets and baseline NIHSS
score as the best model for predicting HT (AUC 0.77). HPrs-PCT at 7mL/100g/min was the
only independent predictor of PH-2 (OR 1, AUC 0.68, p = 0.045).
Conclusions
HPrs-PCT can help predict HT after tPA, and is particularly useful in identifying patients at
low risk of developing HT.
Introduction
Hemorrhagic transformation (HT) can be one of the most devastating complications of
acute ischemic stroke. HT arises when ischemia-induced vascular damage that disrupts the
blood-brain barrier (BBB) is followed by reperfusion [1]. Revascularization with tissue plas-
minogen activator (tPA) increases the risk of HT 10-fold [2]. Clinical guidelines restrict tPA
administration to the first 4.5 h after onset [3], and potential medicolegal concerns about
HT lead to underuse of tPA. Factors associated with increased risk of HT include age, base-
line National Institute of Health Stroke Scale (NIHSS) score, previous antithrombotic treat-
ment, and thrombolytic treatment [4]. Imaging parameters associated with increased risk
of HT include early ischemic changes on non-contrast computed tomography (CT) quanti-
fied using the Alberta Stroke Program Early CT Score (ASPECTS), leukoaraiosis, cerebral
blood volume (CBV) at admission, ischemic lesion volume derived from mean transit time
(MTT) maps, large-vessel occlusions, and poor collaterals on CT angiography (CTA) [5–9],
but no method to predict the development of HT after intravenous tPA has been clinically
approved.
Accurate methods for classifying patients’ risk of HT would make tPA administration
within the current 4.5-hour time-window safer and might enable more patients to benefit
from tPA beyond this window. One approach to identifying patients at risk of HT is to seek
evidence of BBB damage before thrombolysis, In this respect, a promising method to deter-
mine BBB permeability consists of modeling the transfer constant (Ktrans), a metric of BBB
integrity, based on the measurement of the intravascular tracer leakage into the extravascular
space [10,11]. In the normal brain, the BBB is impermeable to the relatively large hydrophilic
molecules in iodinated contrast agents, so Ktrans = 0. A damaged BBB results in Ktrans>0,
and nonzero values represent diffusion across a damaged membrane quantitatively. Commer-
cially available software can semi-automatically generate a functional color map of the brain
permeability.
Growing evidence suggests that BBB permeability can increase in the first few hours after
stroke and that abnormally elevated parameters on perfusion CT (PCT)-derived permeability
maps might indicate ischemia-induced vascular damage [12] and serve as markers to predict
HT [13–19]. However, this approach has not been incorporated into standard of care, in part
due to concerns regarding its sensitivity, specificity, and predictive values. Since the prediction
of HT, and especially PH2, is essential to improve the ratio risk/benefit in patients receiving
tPA, we aimed to determine the performance of high-permeability region size on PCT (HPrs-
PCT) at admission in predicting HT after tPA administration.
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Methods
The Ethics Committee of Hospital Universitari Dr. Josep Trueta of Girona approved this study.
Patients
This is a prospective study of patients with acute stroke treated with tPA at a university hospi-
tal between October 2012 and June 2016. For the purpose of this study, inclusion criteria were
as follows: (1) first-ever middle cerebral artery (MCA) territory infarction treated with tPA
within 4.5 hours of symptom onset, (2) multimodal PCT performed at admission and (3) non-
contrast CT follow-up at 24 hours. Patients presenting motion artifacts were excluded. Patients
without clinical improvement after tPA who underwent mechanical thrombectomy were also
excluded. Stroke severity was assessed by using the NIHSS score before tPA administration
and immediately after the end of the infusion, and at 24, 48 and 72 hours of evolution. Func-
tional outcome was evaluated by using the modified Rankin Scale (mRS) at 3 months; patients
were considered to have achieved a good functional outcome if mRS was2. Stroke mecha-
nism was classified as large artery atherosclerosis, cardioembolic, and of undetermined cause
following the modified TOAST criteria [20].
Imaging protocol
All examinations were performed on a 128-slice CT scanner (Ingenuity; Philips Healthcare,
Best, the Netherlands). We used the following imaging parameters: a) for noncontrast CT:
helical scanning mode, 120kVp, 370mAs, 3-mm slice thickness, 1.5-mm gap, and 512x512
matrix; b) for PCT: cine scanning mode, 100kVp, 100mAs, and four 10-mm slices centered on
the basal ganglia. Image acquisition began 7 seconds after starting injection of a 50-mL bolus
of iodinated contrast agent (Ultravist 300mgI/mL; Bayer HealthCare Pharmaceutical Inc.,
Leverkusen, Germany) into an antecubital vein at 5 mL/second with a power injector. We
acquired first-pass (25 scans, cycle time 2 seconds) and delayed-phase (six contiguous scans,
cycle time 30 seconds) images. There were 3 time frames with an interval of 2 seconds before
bolus arrival. c) For CTA (from aortic arch to cranial vertex): helical scanning mode, 120kVp,
250mAs, 0.9-mm slice thickness, 0.45-mm gap, and 512x512 matrix. We acquired CTA images
after an 80-mL bolus of Ultravist (300mgI/mL) injected at 5 mL/second followed by 20 mL of
saline solution.
Image postprocessing. CBV, cerebral blood flow (CBF), MTT, and time to peak (TTP)
were automatically calculated from PCT data using commercial software (Extended Brilliance
workstation 4.5, Philips Healthcare). Three manually placed regions of interest were traced in
the anterior cerebral artery. The region with the highest enhancement was used as the refer-
ence arterial input function and the superior sagittal sinus as the venous output function. The
infarct core is by default defined as CBV < 2 ml/100g, and the penumbra as MTT > 145% and
CBV 2 ml/100g. [9] BBB permeability was calculated with commercial software based on
the Patlak model (Intellispace Portal system, Philips Healthcare). The Patlak model uses linear-
ized regression for estimating the Ktrans and the blood volume, and it involves fitting regression
lines to observations of time-density curves for each pixel and for intravascular reference func-
tion. The slopes of these lines represent local blood-to-brain transfer constants that indicate
BBB permeability (Ktrans in mL/100g/min). It is important to mention that the leakage is irre-
versible, and the attenuation curves are in a near steady-state. We applied different thresholds
on Ktrans in order to calculate the HPrs-PCT. These automatic calculations set the threshold for
generating five user-independent permeability maps (at 3, 4, 5, 6 and 7 mL/100g/min) (Fig 1).
Anatomic locations normally lacking a BBB (e.g., the ventricular choroid plexuses) often have
a high permeability, so they are excluded.
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CTA source images were reconstructed to 20-mm-thick axial and coronal maximum
intensity projections using Starviewer software (http://gilab.udg.edu/) [21]. To assess vascular
status, we used a modified TIMI grading system, as follows: complete occlusion with no perfu-
sion past the thrombus (TIMI 0); perfusion past the initial occlusion without opacification of
distal vessels (TIMI 1); partial occlusion (TIMI 2), defined as an obstruction with opacification
of the distal vessels; and complete recanalization (TIMI 3). Recanalization was defined as TIMI
2–3 flow in vessels from 1 hour after thrombolysis by using CTA. Collaterals were assessed
with the American Society of Interventional and Therapeutic Neuroradiology/Society of Inter-
ventional Radiology (ASITN/SIR) Collateral Flow Grading System on CTA [22]. The presence
of HT was determined by follow-up CT 24 hours after initial imaging and graded using the
European-Australasian Acute Stroke Study II system into 4 subtypes: hemorrhagic infarct
type 1 (HI-1), hemorrhagic infarct type 2 (HI-2), parenchymal hematoma type 1 (PH-1), or
parenchymal hematoma type 2 (PH-2) [23]. Two neuroradiologists (with over 15 years of
experience) blinded to the clinical data jointly evaluated the vascular status and HT. HT was
considered as symptomatic (sICH) if the patient had clinical deterioration causing an increase
of4 points on the NIHSS [24].
Fig 1. Perfusion CT protocol in a patient with PH-2 in the ischemic right MCA territory following intravenous thrombolysis. Post-processed map
shows a large penumbra in right MCA territory. Note the clearly increased baseline permeability at thresholds of 7 ml/100g/min in the area of the
parenchymal hematoma.
https://doi.org/10.1371/journal.pone.0188238.g001
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Statistical analysis
Patients were classified into 2x2 groups: ‘without HT’ vs ‘with HT’ and ‘without PH-2’ vs ‘with
PH-2’, further classified as symptomatic (sICH) and non-symptomatic (non-sICH). Results
are shown as medians (interquartile ranges) for continuous variables and percentages for cate-
gorical variables. To compare clinical and imaging data between groups, we used univariate
analyses: Fisher’s exact test for categorical data and the Mann-Whitney test for continuous
data. For each outcome, we performed a univariate logistic regression analysis including all
variables collected; we then entered variables significant at P<0.05 into a multivariate logistic
regression model constructed using the backward elimination method. Variables with P<0.05
in the multivariate analyses were considered independent predictors. Odds ratios (OR) with
95% confidence intervals were calculated. Receiver-operating characteristics (ROC) curves
were used to determine the best HPrs-PCT cutoffs for each threshold and associated area
under curve (AUC) and their sensitivity, specificity, positive predictive value (PPV), and nega-
tive predictive value (NPV). We used Minitab version 16.1.1 (Minitab Inc, State College, PA,
USA) for all analyses.
Results
Patient characteristics
Of 357 consecutive tPA-treated patients, 67 were treated beyond 4.5 hours after stroke onset,
23 did not have a non-contrast CT follow-up at 24 hours, 37 did not have PCT at admission,
14 had a posterior cerebral artery infarction, 6 had a anterior cerebral artery infarction, 23 had
a vertebrobasilar territory infarction, and 31 patients underwent mechanical thrombectomy
after tPA treatment. Therefore, 156 patients finally met the inclusion criteria. Table 1 summa-
rizes patient characteristics, imaging data, and HPrs-PCT measurements at different thresh-
olds. Among the patients included in the study, HT occurred in 37 (23.7%): 10 had HI-1, 7 HI-
2, 8 PH-1, and 12 PH-2 (3 with sICH). CBV values did not differ between patients with HT
and those without. Patients with HT had lower platelet count, lower fibrinogen values and
higher NIHSS scores at admission, at 24 hours, and at 72 hours. They also had higher abnor-
mal MTT volumes, larger HPrs-PCT, poorer collateral status, and worse functional outcome at
90 days.
HPrs-PCT characteristics
HT was located in the region of large HPrs-PCT in all cases (Fig 1). Patients with HT had sig-
nificantly larger HPrs-PCT than those without; this was true for all the analyzed thresholds
(Table 1). However, differences in HPrs-PCT between patients with PH-2 and those with
non-PH-2 were significant only at the 7mL/100g/min threshold (Table 1). The HPrs-PCT cut-
offs decreased as the thresholds increased (Table 2). Sensitivity, specificity, and NPV were
higher than PPV for all thresholds. Overall, the NPV of HPrs-PCT had the best performance
(Table 2).
Prediction of HT
In the multivariate analysis, the best model for predicting HT (AUC 0.77) included admission
HPrs-PCT at 7mL/100g/min, platelets, and baseline NIHSS (Table 3). However, the 7mL/
100g/min HPrs-PCT threshold was the only predictor of PH-2 (OR1;AUC = 0.68,95%CI:1–1,
p = 0.045). The sensitivity, specificity, PPV, and NPV of HPrs-PCT >91.83cm
2 for the predic-
tion of PH-2 were 35%, 93.8%, 25%, and 93.8%, respectively (AUC 0.678, 95%CI:0.593–0.763).
High-permeability region size and hemorrhagic transformation after intravenous thrombolysis in stroke
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Table 1. Patient characteristics and univariate statistics between patients with and without PH-2.
Without PH-2 (n = 144) With PH-2 (n = 12) p-value
Demographics
Age(years) 75(66–81.25) 78.5(69.75–81.25) 0.367
Female,% 47.9 75 0.071
Risk factors
Systolic blood pressure(mm Hg) 145(135–154.5) 142.5(129–168.5) 0.695
Diastolic blood pressure(mmHg) 74(66–83) 78.5(64.25–85.5) 0.429
Hypertension,% 70.1 75.0 0.723
Diabetes,% 20.8 16.7 0.731
Smoking,% 18.8 0.0 0.158
Hyperlipidemia,% 38.9 33.3 0.704
Atrial fibrillation,% 31.2 41.7 0.458
Glucose(mmol/L) 128(108–147) 136(106.5–169) 0.814
Fibrinogen(mg/dL) 416(358–481) 341(310–419.5) 0.063
Platelets(x103) 210.5(172–255.5) 178(170–202) 0.086
Stroke etiology
Large artery,% 15.1 9.1 0.835
Cardioembolic,% 47.5 54.5
Undetermined/other,% 37.4 36.4
Clinical Data
NIHSS at admission 13(7–19) 14.5(9–19.25) 0.409
NIHSS at 24 hours 6(2–17.25) 11(6.5–19.5) 0.113
NIHSS at 72 hours 5(0.5–15) 10(8.5–20) 0.068
Imaging Data
Infarct side (right),% 45.7 50.0 0.927
Occlusion pattern (TIMI 0/1-2/3),% 47.1 /47.9/5.0 66.7 /33.3/0.0 0.475
Recanalization (Present), % 70.7 66.7 0.803
ASPECTS 10(8–10) 9.5(8.5–10) 0.645
Admission CBV abnormality(mL) 62.25 (25.66–93.21) 56.90 (19.92–87.93) 0.462
Admission MTT abnormality(mL) 94.19 (45.58–120.13) 109.83 (42.52–123.18) 0.543
Admission penumbra,% 95.83 100 0.680
Collateral status (score 0/1-4)% 4.3/ 95.7 16.7/ 83.3 0.067
Admission HPrs-PCT (cm2)
at 3 mL/100g/min 181.42 (40.98–326.58) 286.97 (106.69–561.30) 0.073
at 4 mL/100g/min 61.76 (15.69–186.06) 120.81 (53.39–327) 0.091
at 5 mL/100g/min 29.18 (6.97–104.21) 76.76 (36.51–204.05) 0.065
at 6 mL/100g/min 15.05 (4.47–52.42) 50.11 (18.51–124.47) 0.068
at 7 mL/100g/min 8.01 (1.83–26.48) 36.42 (12.23–65.46) 0.039
Treatment and Outcome
Stroke onset to CT(min) 159(120–190.75) 150(124.5–213.75) 0.911
tPA dose(mg) 66(58.38–72) 63(56.75–70) 0.318
90-Day modified Rankin score 3(1–4) 4(2–4.25) 0.184
Unless otherwise specified, data are medians with interquartile ranges between parentheses. NIHSS, National Institutes of Health Stroke Score; TIMI,
Thrombosis in Myocardial Infarction; rtPA, recombinant tissue plasminogen activator; ASPECTS, Alberta Stroke Programme Early CT score; CBV, cerebral
blood volume; MTT, mean transit time; HPrs-PCT, high-permeability region size; HT, hemorrhagic transformation; PH, parenchymal hematoma; NA, not
applicable.
https://doi.org/10.1371/journal.pone.0188238.t001
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Discussion
In this study, we analyzed different thresholds for generating user-independent permeability
maps in predicting HT after tPA administration in patients with MCA infarction. Our results
suggest that HPrs-PCT at a threshold of 7mL/100g/min is highly specific for identifying
patients with a low probability of developing HT after tPA administration. More importantly,
HPrs-PCT at 7mL/100g/min lower than the defined cut-off value was the only independent
predictor of PH-2 in our study and so, this method could be useful to improve safety and out-
comes in patients with MCA infarction treated within the current 4.5-hour window.
HT in ischemic tissue after tPA administration is the result of a complex pathophysiologic
process that involves BBB damage as well as many other factors [24–27]. In fact, in our multi-
variate regression analysis, the optimal model to predict HT (AUC = 0.77) included the HPrs-
Table 2. Accuracy of HPrs-PCT thresholds in predicting hemorrhagic transformation.
Area Under Curve (95%
CI)
HPrs-PCT cut-off
(cm2)
Sensitivity Specificity Positive Predictive
Value
Negative Predictive
Value
Prediction Non HT vs
any HT
at 3 mL/100g/min 0.659(0.572,0.745) 241.86 0.541 0.681 0.345 0.827
at 4 mL/100g/min 0.664(0.578,0.750) 281.36 0.570 0.933 0.556 0.804
at 5 mL/100g/min 0.693(0.609,0.777) 59.35 0.595 0.689 0.373 0.845
at 6 mL/100g/min 0.707(0.625,0.790) 56.29 0.486 0.815 0.450 0.836
at 7 mL/100g/min 0.712(0.630,0.795) 29.42 0.514 0.832 0.487 0.846
Prediction PH-2 vs non
PH-2
at 3 mL/100g/min 0.654(0.567,0.740) 492.39 0.333 0.896 0.211 0.942
at 4 mL/100g/min 0.626(0.538,0.714) 357.79 0.250 0.951 0.300 0.938
at 5 mL/100g/min 0.646(0.612,0.730) 116.50 0.333 0.792 0.118 0.934
at 6 mL/100g/min 0.665(0.579,0.751) 114.05 0.333 0.910 0.235 0.942
at 7 mL/100g/min 0.678(0.593,0.763) 91.83 0.350 0.938 0.250 0.938
https://doi.org/10.1371/journal.pone.0188238.t002
Table 3. Models selected from multiple regression analyses for predicting hemorrhagic transformation.
Any hemorrhagic transformation
Independent Variable β coefficient (x10-3) Odds Ratio (95%CI) p-value AUC
Univariate Analysis
HPrs-PCT at 7mL/100g/min 0.03 1.00(1.00–1.00) <0.001 0.66
Admission MTT abnormality (mL) 0.01 1.00(1.00–1.00) 0.031 0.62
Admission NIHSS 99,41 1.10(1.04–1.17) 0.001 0.68
Platelets -0.01 1.00 (1.00–1.00) 0.030 0.62
Multivariate Analysis Platelets -0.01 1.00(1.00–1.00) 0.013 0.73
Admission NIHSS 111.86 1.11(1.05–1.19) <0.001
HPrs-PCT at 7 mL/100g/min 0.03 1.00 (1.00–1.00) 0.003 0.73
Admission NIHSS 85.93 1.07(1.01–1.13) 0.006
HPrs-PCT at 7mL/100g/min 0.03 1.00(1.00–1.00) 0.004 0.77
Platelets -0.01 1.00(1.00–1.00) 0.018
Admission NIHSS 102.28 1.11(1.04–1.19) 0.003
PH-2
Univariate Analysis
PSA at 7mL/100g/min 0.04 1.00(1.00–1.00) 0.045 0.68
https://doi.org/10.1371/journal.pone.0188238.t003
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PCT threshold at 7mL/100g/min together with platelets and baseline NIHSS, and although
HPrs-PCT at this threshold was the only predictor of PH-2, the sensitivity and PPV were low,
making it necessary to consider other clinical and imaging parameters to avoid overestimating
the risk of bleeding. Previously published data have shown that several parameters evaluated
by CT perfusion might be useful for the prediction of HT. In this respect, lower CBV values
[28,29] as well as higher MTT [6] and Tmax>14 seg [30] have been reported to be associated
with intracranial hemorrhage in patients with acute ischemic stroke. In spite of this, the results
cannot be considered as cleary consistent, since both MTT and CBV were included in these
studies but the results in terms of prediction of bleeding were different depending on the study.
According to this variability, in our study we have found lower CBV values in patients with HT
as well as in patients with PH-2, although the differences were not significant. Regarding MTT,
we have also found lower values in patients with HT and PH-2, but the values reached statistical
significance only when the comparison was made between patients with and without HT.
Since HT is the result of BBB disruption, imaging techniques to characterize BBB status
may be more useful in identifying patients who might safely benefit from these therapies. Pre-
dicting which patients will develop HT after tPA is a challenge and the quantification of BBB
damage after stroke is probably essential in overcoming this challenge. In agreement with this
idea, levels of biomarkers involved in the pathogenesis of BBB damage, such as matrix metallo-
protease-9 and cellular fibronectin, have been demonstrated to be highly predictive of severe
HT after tPA administration [26].
Accumulating evidence suggests that permeability imaging features might be good predic-
tors of HT. However, the best BBB-permeability volume threshold to predict HT by PCT has
not been established yet, probably due to differences in image acquisition and data modeling.
Moreover, inclusion criteria among the patients studied were not homogeneus and the sample
sizes were usually small. In fact, Lin et al. reported that any threshold between 4.99mL/100g/
min (S = 100%; Sp = 80%) and 5.88mL/100g/min (S = 66.7%; Sp = 100%) can be used to pre-
dict HT after tPA administration. They used first-pass dynamic PCT and the study included
50 patients with acute ischemic stroke, 18 of whom had received tPA. Only six patients
had HT, 3 in the group treated with thrombolysis [19]. In the study from Aviv et al., which
included 41 patients with acute ischemic stroke, 22 treated with tPA, the best threshold for pre-
dicting HT was 0.23mL/100g/min (S = 77%; Sp = 94%). Twenty-tree patients developed HT in
this study (15, HI and 8, PH). Permeability surface (PS) was higher in patients with HT com-
pared to those without, but no differences were found between patients with HI and PH. On
the other hand, PS was similar in patients with HT regardless of the administration of tPA
[16]. With the objective of evaluating the predictive capacity of BBB permeability measure-
ments on the development of sICH, Hom et al. analyzed a dataset of 32 patients with acute
ischemic stroke by using delayed-adquisition PCT data and the Patlak model. Only 3 patients
developed sICH. In spite of this small sample size, a threshold of 7mL/100g/min was found to
be predictive of this complication (S = 100%; Sp = 79%) [15]. Ozkul-Wermester et al. [14]
studied a total of 86 patients, 27 of whom developed HT. PS was significantly higher in patients
with HT. The authors reported 96% NPV in predicting HT using a PS threshold>0.84ml/
100g/min. In this study, the authors also found a poor collateral status to be associated with
HT, a fact that is probably related to a more severe BBB disruption, since pial collateral arteries
seem to help irrigate ischemic territory dowstream of the trombus [8,14]. According to this, a
poor collateral status has also been demonstrated to be associated with HT in our study. More
recently, Yen et al. evaluated the relative PS (rPS) area (ratio of the PS on the side of the acute
ischemic stroke to the PS on the contralateral side) and compared this value in patients with
and without HT. The study included 42 patients, 15 of whom had HT. Patients with a mean
rPS of 1.3 had an increased likelihood of subsequent HT (S = 71.4; Sp = 78.6; PPV = 62.5;
High-permeability region size and hemorrhagic transformation after intravenous thrombolysis in stroke
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NPV = 84.6). However, no difference was found between petechial and parenchymal hemor-
rhagic events [13].
Our study included the biggest sample size previously studied with the objective of deter-
mining the capacity of HPrs-PCT in the prediction of intracranial bleeding after tPA treatment.
Unless other studies, we only included patients treated with tPA because the increased risk of
HT and the worse prognosis associated with this complication could be avoided if we were
able to improve the selection of treated patients. Our results show that, although different
thresholds did not differ significantly in their ability to predict any HT, the only independent
predictor for PH-2 was the 7mL/100g/min threshold. In agreement with previously published
data, patients with HT also had higher baseline NIHSS and larger ischemic lesions, as sug-
gested by MTT maps [4,14].
However, in our study we have to acknowledge certain limitations. This is a single-center
study that may not be representative of more diverse populations, thus precluding the generali-
zation of our results. On the other hand, although we have shown that PCT-PCA maps seem to
be useful for the prediction of PH-2 after tPA treament, the small simple size of sICH did not
allow conclusions to be drawn in this subgroup of patients, a fact that is commom among previ-
ously published data. In fact, only one study has reported an association between PS and the
development of sICH, but only 3 patients with sICH were evaluated [15]. As this particular sub-
group of patients with intracranial bleeding are the most clinically relevant, larger cohorts of
this group need to be assessed to clarify the usefulness of HPrs-PCT maps in predicting this
complication. Reported permeability measurements in our study are different from those previ-
ously reported. The molecular size and charge of the contrast agent used, acquisition protocol
(especially duration) and post-processing techniques, noise level, ROI location, infarct core/
penumbra definitions, as well as the method used for permeability analysis, may be factors that
might explain the difference in permeability values reported in the literature. Changes in the
BBB during ischemia and reperfusion are dynamic and complex, so various thresholds could be
used to process the permeability maps in clinical scenarios, and which would provide the best
information remains to be determined. Standardized HPrs-PCT calculation software and fur-
ther studies are needed to validate an optimal threshold to predict HT. In our study, we focused
only on HPrs-PCT maps because they are quickly (<1 minute) and easily obtained after image
acquisition with user-independent automatic segmentation and no need to draw regions of
interest, making this approach feasible in acute settings. Nevertheless, models integrating other
permeability indexes might provide more accurate predictions. Although 7mL/100g/min was
found to be the optimal threshold to predict HT in our study, we cannot rule out that baseline
permeability thresholds over the tested range or thresholds in our study may have a greater pre-
dictive capacity. Moreover, it has been reported that rPS measured in the infarct core with non-
linear regresssion (NRL) method has a superior discriminative power for the prediction of HT
than Ktrans measured with either Patlak analysis with a fixed offset or NLR, and conventional
perfusion parameters. [31] Unfortunately, in our study we did not perform comparisons of the
PS values between ipsilateral and contralateral areas, so we do not have rPS values to determine
whether this parameter may have given us a better estimate of the hemorrhagic transformation
risk. On the other hand, previous data have also shown that rPS does not seem to discriminate
between less and more severe HT, [16] and so further studies are necessary in order to clarify
the value of this parameter in the prediction of clinically meaningful HT.
Conclusions
Our study demonstrates, in a large series of patients with MCA infarction, that HPrs-PCT
can be useful in the prediction of intracranial bleeding after tPA administration with 4.5
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hours of symptom onset. More specifically, HPrs-PCT can reliably identify patients at low
risk of developing HT and PH-2. By using this approach, patients with low risk of bleeding
beyond the current therapeutic window for tPA administration could potentially be identi-
fied and safely treated. Further studies are, however, necessary in order to define the most
accurate thresholds for the prediction of bleeding and to determine how HPrs-PCT might
refine clinical decision making in acute stroke patients treated within and beyond the current
tPA therapeutic window.
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